Best Niche Antibody-based Biologics


Jeng-Shin Lee

A seasoned molecular biologist with proven record in gene transfer technology and early product development in biologics, gene and cell therapy. Jeng-Shin was the Deputy Director at Harvard Gene Therapy Initiative and established broad network and supported multiple successful IND submissions targeting muscle diseases and cancer. He was a post-doctoral fellow in Professor Richard Mulligan’s laboratory at Harvard Medical School. Jeng-Shin received his Ph.D. from Harvard University and M.D. from National Taiwan University.